Provention Bio Operating Cycle 2011-2026 | PRVB

Annual Operating Cycle Provention Bio

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
19.2	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Maximum	Minimum	Average
19.2	19.2	19.2

Issuer	Operating Cycle	Price	% 24h	Market Cap	Country
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	32	-	-1.52 %	$ 24.7 M	USA
Alnylam Pharmaceuticals ALNY	102	$ 320.13	-3.98 %	$ 41.9 B	USA
Midatech Pharma plc MTP	245	-	-18.52 %	$ 27.3 M	Britain
Amphastar Pharmaceuticals AMPH	237	$ 21.81	0.6 %	$ 1.02 B	USA
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	115	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
Akebia Therapeutics AKBA	210	$ 1.35	-12.9 %	$ 347 M	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
Aquestive Therapeutics AQST	223	$ 4.26	0.47 %	$ 456 M	USA
AstraZeneca PLC AZN	206	-	-	$ 96.9 B	Britain
Arcutis Biotherapeutics ARQT	291	$ 24.19	-1.59 %	$ 3.08 B	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
BioDelivery Sciences International BDSI	436	-	-4.8 %	$ 255 M	USA
Autolus Therapeutics plc AUTL	129	$ 1.61	8.05 %	$ 428 M	Britain
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
bluebird bio BLUE	127	-	-	$ 546 M	USA
Cidara Therapeutics CDTX	2.26 K	-	-	$ 1.41 B	USA
BioXcel Therapeutics BTAI	1.66 K	$ 1.07	1.9 %	$ 13.1 M	USA
ChromaDex Corporation CDXC	24.7	-	-0.88 %	$ 598 M	USA